FDA Investigator Muralidhara B Gavini, PhD

Muralidhara B Gavini, PhD has inspections in 6 countries as of 27 Oct 2023. Muralidhara B Gavini, PhD has collaborated with a combinined 6394 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
139
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
India, Ireland, Germany, Canada, United States of America
Co-Investigator(s):
Adalberto Cajigas, Adaliz Santaliz Cruz, Ademola O Daramola, Aditi S Thakur, Alan P Kurtzberg, Albinus M D Sa, Alicia M Mozzachio, Allen F Hall, Anastasia M Shields, Andrew J Barrowcliff, Angela E Glenn, Anissa M Vargas, Anita Narula, PhD, Anjali Shukla, PhD, Ann L Demarco, Annette Melendez, Anthony J Ladner, Ariel Cruz Figueroa, Arsen Karapetyan, Atul J Agrawal, Azza Talaat, Barbara Janine Breithaupt, Barbara L Rogolsky, Bichsa T Tran, Bijoy Panicker, Blondell W Johnson, Bonita S Chester, Brandon C Heitmeier, Brittany D Terhar, Bryan L Mcguckin, Carl Lee, Carla A Norris, Carla J Lundi, Carrie A Hughes, CDR Ileana Barreto Pettit, CDR Rochelle B Young, RPh, MSA, Chaoying C Ma, Charanjeet Jassal, Charisse K Green, Charles D Brown, Charles M Edwards, Charles R Cote, RIC, Cheryl A Clausen, Christopher D Leach, Christopher S Keating, Chunsheng Cai, PhD, Claire M Minden, Conner N Mann, Constantin Y Philopoulos, Cynthia Jim, CSO, Cynthia M Goudeau, Cynthia R Gibson, Dale A Nyberg, Dana M Klimavicz, Daniel J Roberts, Daniel L Obrzut, Darren S Brown, Dawn C Olenjack, Dawn E Barkans, Dayna I Martinez, Debra I Love, Demitria J Xiradakis, Denise L Burosh, Dennis Cantellops Paite, Devaughn Edwards, Deyaa Shaheen, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Dongping Dai, PhD, Douglas A Campbell, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Gopa Biswas, PhD, Dr. Jason R Caballero, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Edwin Martinez, Edwin Melendez, Eileen A Liu, Eric M Mueller, PharmD, Eric S Weilage, Erika V Butler, Farhana Khan, Felix Maldonado, Francis A Guidry, Frederick Razzaghi, Gam S Zamil, Gayle S Lawson, George Pyramides, German Rivera, Grace E Mcnally, Guerlain Ulysse, Gwyn G Dickinson, H Ljamilla Selby, Haitao Li, Hala L Selby, Hasan A Irier, PhD, Helen B Ricalde, Iraida Ortiz, Ivis L Negron, Ivis Lnegron Torres, Ivy E Sweeney, Jai P Singh, James A Liubicich, James C Maclaughlin, James L Dunnie, Jr, James S Cartwright, Janete F Guardia, Jared P Stevens, Jason K Morgan, Javier O Vega, Jawaid Hamid, Jay V Jariwala, Jeffery A Hangartner, Jeffrey P Raimondi, Jennifer C Adams, Jennifer L Gustavus, Jennifer L Huntington, Jessica L Pressley, Joanne E King, Joanne Heim, Joanne M Schlossin, Joel D Martinez, Jogy George, Jonah S Ufferfilge, Jorge L Guadalupe, Jose A Cruz, Jose Acruz Gonzalez, Jose Alopez Rubet, José E Meléndez, Jose E Melendez, DDC, Jose M Cayuela, Jose Martinez, Jr, Jose R Hernandez, Jose R Lopez, Jose Velez, Julianne C Mccullough, June P Page, Junho Pak, Justin A Boyd, Kara D Dobbin, Karen Takahashi, Kari M Johansen, Katherine Szestypalow, Kathryn E Ogger, Kejun Cheng, Kelli F Dobilas, Kellia N Hicks, Kenneth H Williams, Kent C Faul, Kevin A Gonzalez, Kevin P Foley, Kham Phommachanh, Kristen Nickens, PhD, Kristy A Zielny, Lakshmi Narasimhan, PhD, Larry K Austin, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Laurie Nelson, Laurimer Kuilan Torres, Lawrence Harmon, Jr, Lequita M Mayhew, Li Hongpaul Yeh, PhD, Libia M Lugo, Linda F Murphy, Lindsey Brown, PhD, Lisa R Hilliar, Lourdes Andujar, LT Daveta L Bailey, LT Richard A Lyght, LT Tamara J Henderson, Lucas B Leake, Luella J Rossi, Luis A Dasta, Luis M Burgos Medero, Makini Cobourne Duval, PhD, Maotang Zhou, PhD, Marcellinus D Dordunoo, Marcus A Ray, Maria Estrella, Maria Gutierrez Lugo, PhD, Maria V Price, Marie F Morin, Marijo B Kambere, PhD, Martin K Yan, PhD, Martin Yan, Massoud Motamed, Matthew B Casale, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Merry Christie, PhD, Meyer J Slobotsky, Michael A Charles, Michael A Taylor, Michael G Sinkevich, Michael L Casner, Michael L Chasey, Michael R Goga, Michael Shanks, MS, Michele L Obert, Michele Perry Williams, Michelle Y Clark Stuart, Miguel A Martinez, Min Tang, Minh D Phan, Mohsen Rajabi Abhari, FDA, Monica Cburgos Garcia, Muralidhara D Givani, Nadeem I Chaudhry, Nancy M Espinal, Nayan J Patel, Neal L Adams, Nicole E Knowlton, Nije A Thomas, Niketa Patel, Nikki S Ramirez, Nilufer M Tampal, PhD, Nilufer M Tampalm, PhD, Noreen Muniz, Pal S Mayasandra, Pankaj H Amin, Paraluman S Leonin, Parul M Patel, Patrice S Hall, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Bellamy, Paula R Katz, Peter E Baker, Philip F Istafanos, DMV, MS, Pratik S Upadhyay, DDC, Qin Xu, Rafael E Arroyo, Rafael Nevarez Nieves, Rajiv R Srivastava, Ralph A Erickson, Ralph H Vocque, Ramon A Hernandez, Raquel Gonzalez Rivera, Raymond T Oji, Reba A Gates, Rebeca M Melendez, Rebecca E Dombrowski, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard H Penta, Richard W Berning, Richmond K Yip, Rita K Kabaso, Robert C Steyert, Robert D Tollefsen, Robert J Doyle, Robert J Maffei, Robert J Martin, Robert M Barbosa, Ross J Grigsby, Rumany C Penn, PharmD, Russell J Glapion, S Lori Brown, PhD MPH, Saied A Asbagh, Saleem A Akhtar, Sandra A Hughes, Sangeeta M Khurana, PhD, Santos E Camara, Sarah E Mcmullen, Sarah Forney, Sarah Ibrahim, Sarah Kennett, PhD, Satheesh Thomas, Saundrea A Munroe, Scott B Laufenberg, Scott N Lim, Scott R Nichols, PhD, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Sherry G Bous, Shirley J Berryman, Shirshendu K Deb, PhD, Simone E Pitts, Sixto M Mercado Rios, Sneha S Patel, Sony Mathews, Sripal R Mada, PhD, Sriram Susrambraham, Stacie A Woods, Stephanie A Slater, MS, Stephen D Brown, Stephen D Eich, Steven A Gonzales, Steven B Barber, Steven D Kehoe, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Syed N Ali, Tajah L Blackburn, Tamil Arasu, PhD, Tawny L Colling, Ted L Anderson, Tenzin Jangchup, Teresa I Navas, Thomas J Arista, Tiara M Brown, Timothy T Kapsala, Tomika L Bivens, Tonia F Bernard, Torrance J Slayton, Tracey L Harris, Tracy K Li, Tricia S Martinez, Truong Xuan Nguyen (Andy), Tsedenia Woldehanna, Unnee Ranjan, Uttaniti Limchumroon (Tom), Valerie L Whipp, Vilmary Negron Rodriguez, Virgilio F Pacio, CSO, Vivin George, Vlada Matusovsky, Walden H Lee, Wanda J Torres, Wayne D Mcgrath, Wayne T Smith, Wei Huaemily Wu, William A Warnick, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD, Xiomara Copeland, Yasamin Ameri, Yumi J Hiramine, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zedong Dong, Zhaoyang Meng, Zhong Li, PhD

Muralidhara B Gavini, PhD's Documents

Publish Date Document Type Title
January, 2012 FDA 483 Wockhardt Limited - Form 483, 2012-01-21
May, 2004 FDA 483 Response Neuland Laboratories, Ltd. (Unit I) - Form 483R, 2004-06-28
December, 2012 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2012-12-12
July, 2012 FDA 483 Ipca Laboratories Limited - Form 483, 2012-08-03
December, 2001 FDA 483 Response Sun Pharmaceutical Industries Limited - Form 483R, 2001-12-11
May, 2004 EIR Neuland Laboratories, Ltd. (Unit I) - EIR, 2004-08-01
November, 2003 FDA 483 AURORE PHARMACEUTICALS PRIVATE LIMITED - Form 483, 2003-11-25
July, 2011 EIR Xylo Chem Industries - EIR, 2011-07-16
August, 2006 FDA 483 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - Form 483, 2006-08-07
May, 2012 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2012-05-01
November, 2000 EIR Solara Active Pharma Sciences Limited - EIR, 2000-11-03
April, 2011 FDA 483 Pharmazell (India) Private Limited - Form 483, 2011-04-01
May, 2004 FDA 483 Response DR. REDDY'S LABORATORIES LIMITED - Form 483R, 2004-08-06
April, 2012 FDA 483 Laxai Life Sciences Private Limited - Form 483, 2012-04-16
November, 2013 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2013-11-23
July, 2011 FDA 483 Xylo Chem Industries - Form 483, 2011-07-16
June, 2012 EIR Sun Pharmaceutical Industries Limited - EIR, 2012-06-13
April, 2004 EIR Dr. Reddy's Laboratories - EIR, 2004-07-06
December, 2001 EIR Sun Pharmaceutical Industries Limited - EIR, 2001-12-21
May, 2004 FDA 483 NEULAND LABORATORIES LIMITED - Form 483, 2004-05-14
April, 2004 FDA 483 DR. REDDY'S LABORATORIES, LTD. - Form 483, 2004-04-30
December, 2001 EIR Sun Pharmaceutical Industries Limited - EIR, 2001-12-11
May, 2004 EIR DR. REDDY'S LABORATORIES LIMITED - EIR, 2004-07-23
December, 2006 EIR Biocon Biologics Limited - EIR, 2006-12-29
July, 2011 FDA 483 DIVI'S LABORATORIES LIMITED - Form 483, 2011-07-30
November, 2010 FDA 483 Emcure Pharmaceuticals Limited - Form 483, 2010-11-22
February, 2010 FDA 483 LUPIN LIMITED - Form 483, 2010-02-12
July, 2011 FDA 483 Yag Mag Labs Private Limited - Form 483, 2011-07-02
April, 2004 FDA 483 Response Dr. Reddy's Laboratories - Form 483R, 2004-05-19
April, 2009 FDA 483 Micro Labs Limited - Form 483, 2009-04-17
November, 2000 FDA 483 Shasun Chemicals and Drugs Ltd. - Form 483, 2000-11-03
August, 2009 FDA 483 EMCURE PHARMACEUTICALS LIMITED - Form 483, 2009-08-19
November, 2003 FDA 483 SMS PHARMACEUTICALS LTD., UNIT-II - Form 483, 2003-11-20
January, 2009 FDA 483 Suven Pharmaceuticals Limited - Form 483, 2009-01-07
July, 2012 EIR Ipca Laboratories Limited - EIR, 2012-07-31
June, 2012 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2012-06-13
April, 2011 EIR Solara Active Pharma Sciences Limited - EIR, 2011-04-08
May, 2013 FDA 483 Sai Life Sciences Limited - Form 483, 2013-05-08
October, 2013 FDA 483 Response MYLAN LABORATORIES LIMITED - Form 483R, 2013-11-07
January, 2013 FDA 483 Response Torrent Pharmaceuticals Limited - Form 483R, 2013-01-29
January, 2014 FDA 483 Choksi Laboratories Limited - Form 483, 2014-01-12
August, 2010 FDA 483 Synbiotics Limited - Form 483, 2010-08-27
December, 2001 FDA 483 Response Sun Pharmaceutical Industries Limited - Form 483R, 2001-12-21
August, 2013 FDA 483 Zydus Lifesciences Limited - Form 483, 2013-08-19
October, 2013 EIR MYLAN LABORATORIES LIMITED - EIR, 2013-10-19
June, 2012 FDA 483 Sun Pharmaceutical Industries Ltd. - Form 483, 2012-06-13
December, 2013 FDA 483 Atul Ltd - Form 483, 2013-12-21
May, 2010 FDA 483 Ipca Laboratories Limited - Form 483, 2010-05-28
April, 2010 FDA 483 Apotex Research Private Limited - Form 483, 2010-04-17
April, 2011 FDA 483 Solara Active Pharma Sciences Limited - Form 483, 2011-04-08
November, 2000 FDA 483 Response Cadila Pharmaceuticals Limited - Form 483R, 2001-01-03
May, 2013 EIR Sai Life Sciences Limited - EIR, 2013-05-08
November, 2002 EIR Solara Active Pharma Sciences Limited - EIR, 2002-12-31
December, 2003 EIR Biocon Limited - EIR, 2003-12-05
October, 2013 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2013-10-19
November, 2000 EIR Cadila Pharmaceuticals Limited - EIR, 2000-11-08
August, 2006 EIR Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company - EIR, 2006-08-07
September, 2012 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2012-09-30

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more